Literature DB >> 19440117

Autoimmune forms of hypoglycemia.

Beatrice C Lupsa1, Angeline Y Chong, Elaine K Cochran, Maria A Soos, Robert K Semple, Phillip Gorden.   

Abstract

Autoimmune syndromes are a rare cause of hypoglycemia characterized by elevated levels of insulin in the presence of either anti-insulin antibodies (insulin autoimmune syndrome) or anti-insulin receptor antibodies (type B insulin resistance). Insulin autoimmune syndrome is the third leading cause of hypoglycemia in Japan, but has rarely been described in the non-Asian population.In the current study, we report the clinical and biochemical characteristics and clinical course of 2 white patients with insulin autoimmune syndrome, and present a literature review of non-Asian patients reported with insulin autoimmune syndrome. Also, we describe the clinical and biochemical characteristics of patients reported in the literature with type B insulin resistance who manifested hypoglycemia. We compare the clinical and laboratory features of insulin autoimmune syndrome and type B insulin resistance with each other and with other forms of hyperinsulinemic hypoglycemia.Autoimmune forms of hypoglycemia are uncommon. However, they should be considered in any patient with hypoglycemia in the setting of unsuppressed insulin levels associated with anti-insulin or anti-insulin receptor antibodies. Making the correct diagnosis may spare a hypoglycemic patient from an unnecessary pancreatic surgical procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440117     DOI: 10.1097/MD.0b013e3181a5b42e

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  51 in total

1.  Other Antibodies Resulting in Diabetes Mellitus: Type B Insulin Resistance and Insulin Autoimmune Syndrome.

Authors:  Elaine Cochran; Rebecca J Brown; Phillip Gorden
Journal:  AACE Clin Case Rep       Date:  2016

2.  Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin.

Authors:  Dagmara I Kisiela; Victoria B Rodriguez; Veronika Tchesnokova; Hovhannes Avagyan; Pavel Aprikian; Yan Liu; Xue-Ru Wu; Wendy E Thomas; Evgeni V Sokurenko
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 3.  Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.

Authors:  Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

4.  NFATc2 (NFAT1) assists BCR-mediated anergy in anti-insulin B cells.

Authors:  Rachel H Bonami; William T Wolfle; James W Thomas; Peggy L Kendall
Journal:  Mol Immunol       Date:  2014-02-06       Impact factor: 4.407

5.  Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease.

Authors:  Sun Hee Lee; Seung Hwan Oh; Woo Yeong Chung
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-03-31

6.  Hypoglycaemia revealing heterozygous insulin receptor mutations.

Authors:  V Preumont; C Feincoeur; O Lascols; C Courtillot; P Touraine; D Maiter; C Vigouroux
Journal:  Diabetes Metab       Date:  2016-07-26       Impact factor: 6.041

Review 7.  Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review.

Authors:  Sigong Zhang; Guochun Wang; Jinping Wang
Journal:  Clin Rheumatol       Date:  2012-10-03       Impact factor: 2.980

8.  Spontaneous hypoglycemia: diagnostic evaluation and management.

Authors:  Leelavathy Kandaswamy; Rajeev Raghavan; Joseph M Pappachan
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

Review 9.  The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Authors:  M V Davi; A Pia; V Guarnotta; G Pizza; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2016-09-13       Impact factor: 4.256

Review 10.  Syndromic insulin resistance: models for the therapeutic basis of the metabolic syndrome and other targets of insulin resistance.

Authors:  Phillip Gorden; Elika Safar Zadeh; Elaine Cochran; Rebecca J Brown
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.